Blume Capital Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-700
| Closed | -$14K | – | 302 |
|
2021
Q3 | $14K | Hold |
700
| – | – | 0.01% | 241 |
|
2021
Q2 | $15K | Hold |
700
| – | – | 0.01% | 224 |
|
2021
Q1 | $17K | Hold |
700
| – | – | 0.01% | 205 |
|
2020
Q4 | $18K | Hold |
700
| – | – | 0.01% | 169 |
|
2020
Q3 | $12K | Hold |
700
| – | – | 0.01% | 171 |
|
2020
Q2 | $12K | Hold |
700
| – | – | 0.01% | 166 |
|
2020
Q1 | $8K | Hold |
700
| – | – | 0.01% | 181 |
|
2019
Q4 | $8K | Hold |
700
| – | – | ﹤0.01% | 190 |
|
2019
Q3 | $9K | Hold |
700
| – | – | ﹤0.01% | 186 |
|
2019
Q2 | $8K | Hold |
700
| – | – | ﹤0.01% | 184 |
|
2019
Q1 | $8K | Hold |
700
| – | – | ﹤0.01% | 196 |
|
2018
Q4 | $9K | Hold |
700
| – | – | 0.01% | 186 |
|
2018
Q3 | $10K | Hold |
700
| – | – | 0.01% | 162 |
|
2018
Q2 | $11K | Hold |
700
| – | – | 0.01% | 159 |
|
2018
Q1 | $11K | Hold |
700
| – | – | 0.01% | 171 |
|
2017
Q4 | $13K | Hold |
700
| – | – | 0.01% | 181 |
|
2017
Q3 | $14K | Hold |
700
| – | – | 0.01% | 183 |
|
2017
Q2 | $8K | Hold |
700
| – | – | ﹤0.01% | 166 |
|
2017
Q1 | $8K | Hold |
700
| – | – | ﹤0.01% | 158 |
|
2016
Q4 | $5K | Hold |
700
| – | – | ﹤0.01% | 182 |
|
2016
Q3 | $5K | Hold |
700
| – | – | ﹤0.01% | 173 |
|
2016
Q2 | $4K | Hold |
700
| – | – | ﹤0.01% | 196 |
|
2016
Q1 | $3K | Hold |
700
| – | – | ﹤0.01% | 222 |
|
2015
Q4 | $3K | Hold |
700
| – | – | ﹤0.01% | 219 |
|
2015
Q3 | $3K | Hold |
700
| – | – | ﹤0.01% | 221 |
|
2015
Q2 | $4K | Hold |
700
| – | – | ﹤0.01% | 212 |
|
2015
Q1 | $4K | Hold |
700
| – | – | ﹤0.01% | 254 |
|
2014
Q4 | $2K | Hold |
700
| – | – | ﹤0.01% | 281 |
|
2014
Q3 | $2K | Hold |
700
| – | – | ﹤0.01% | 186 |
|
2014
Q2 | $2K | Hold |
700
| – | – | ﹤0.01% | 204 |
|
2014
Q1 | $3K | Hold |
700
| – | – | ﹤0.01% | 220 |
|
2013
Q4 | $2K | Buy |
+700
| New | +$2K | ﹤0.01% | 249 |
|